Truist Financial’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,768
Closed -$257K 2707
2021
Q3
$257K Buy
+4,768
New +$257K ﹤0.01% 2403